ANI PHARMACEUTICALS, INC Disposal Group, Including Discontinued Operation, Liabilities, Current
ANI PHARMACEUTICALS, INC (ANIP) had Disposal Group, Including Discontinued Operation, Liabilities, Current of $131.61 thousand as of 2013-09-30, per its 10-Q filed 2013-11-07.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent · last filed 2013-11-07
- 2013-09-30: Disposal Group, Including Discontinued Operation, Liabilities, Current $131.61K.
- 2013-06-30: Disposal Group, Including Discontinued Operation, Liabilities, Current $366.39K.
- 2012-12-31: Disposal Group, Including Discontinued Operation, Liabilities, Current $370.77K.
| Period end | Disposal Group, Including Discontinued Operation, Liabilities, Current |
|---|---|
| 2013-09-30 | $131.61K 10-Q · filed 2013-11-07 |
| 2013-06-30 | $366.39K 10-Q · filed 2013-08-09 |
| 2012-12-31 | $370.77K 10-Q · filed 2013-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |